Understand the source comparison
Cartalax Dosage Protocol Guide Comparison
Daily Dosage 200–400 mcg subcutaneous 100–200 mcg subcutaneous 200 mcg every 48 hours Standard dose produces measurable effects in 10–14 days; extended and maintenance approaches require 20–25 days for equivalent outcomes Cycle Duration 10–20 days continuous 3
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Daily Dosage
- 200–400 mcg subcutaneous
- 100–200 mcg subcutaneous
- 200 mcg every 48 hours
- Standard dose produces measurable effects in 10–14 days; extended and maintenance approaches require 20–25 days for equivalent outcomes
- Cycle Duration
- 10–20 days continuous
- 30–40 days continuous
- Ongoing with 2-day intervals
- 10–20 day cycles align with published efficacy data; extended cycles risk receptor downregulation without proportional benefit increases
- Rest Interval
- 3–6 months between cycles
- 6–9 months between cycles
- No formal rest period
- 3–6 month intervals allow full receptor recovery; maintenance protocols show diminishing returns after 60–90 days
- Reconstitution Volume
- 1 mL per 1 mg vial
- 2 mL per 1 mg vial (diluted)
- Standard 1:1 ratio provides optimal concentration for accurate dosing; diluted preparations increase injection volume without stability benefit
- Storage Temperature
- 2–8°C refrigerated
- All protocols require identical cold-chain storage; there is no room-temperature-stable reconstituted form